依来努单抗 T76863

Product Introduction
Bioactivity


英文名: Elezanumab

描述: Elezanumab(ABT-555) 是一种有效的人抗 RGMa 单克隆抗体。Elezanumab 通过 SMAD1/5/8 通路发挥对 RGMa 介导的 BMP 信号传导的抑制作用，IC50 约为 97 pM。在神经元损伤和脱髓鞘模型中，Elezanumab 促进神经再生、神经保护和神经恢复。Elezanumab 促进皮质脊髓轴突生长为脊髓灰质，并增强腹角的血清素能神经支配，形成颈部病变尾部的突触连接。

体内活性: Elezanumab (1-10 mg/kg; IV; weekly; 5 times) promotes axonal regeneration and prevents axonal regeneration in the female Lewis rat model of optic nerve crush and optic neuritis Retinal nerve fiber layer degeneration.[1]Elezanumab (0.01, 0.1, 1, 10 mg/kg; IV; once weekly; 3 times) promotes axonal regeneration in a spine-targeted female Lewis rat model of experimental autoimmune encephalomyelitis (EAE) and remyelination, reducing the area of inflammatory lesions and improving functional recovery.[1]

存储条件: store at low temperaturestore at -20°C

关键字: ABT 555 | Elezanumab | ABT555

相关产品: Galunisertib | K02288 | Kartogenin | R-268712 | Dorsomorphin dihydrochloride | Fresolimumab | SB-431542 | LY-364947 | Disitertide acetate | TP0427736

依来努单抗 T76863信息由TargetMol中国为您提供，如您想了解更多关于依来努单抗 T76863报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途